Does Insurance Cover GLP-1 for Sleep Apnea?
The RX Index is a pricing intelligence and comparison resource for GLP-1 telehealth providers.
Yes — insurance can cover a GLP-1 for sleep apnea. But only one GLP-1 actually qualifies, and the reason it qualifies is the part most people miss. That drug is Zepbound (tirzepatide). In December 2024, the FDA approved it for moderate-to-severe obstructive sleep apnea in adults with obesity — the first prescription medicine ever approved to treat sleep apnea.
The question isn't whether a "GLP-1" is covered. It's whether Zepbound, prescribed for sleep apnea, is on your plan — and whether you have the documentation to back it up.
Quick decision: find yourself in this table
| If this is your situation | Do this first |
|---|---|
| You have sleep apnea + obesity + commercial insurance | Run a free coverage check and ask specifically about Zepbound for sleep apnea |
| You're on Medicare Part D | Ask about Zepbound for sleep apnea under regular Part D — not the $50 Bridge |
| Your plan already denied it as "weight loss" | Appeal using the sleep apnea diagnosis + your sleep study |
| You don't have a sleep study yet | Start with a sleep test — insurers need proof on paper |
| You're paying cash | Compare real Zepbound self-pay prices before you commit |
Check whether your plan covers Zepbound for sleep apnea — free, in a few minutes.
Ro's free GLP-1 Insurance Coverage Checker gives you a personalized coverage report and tells you whether your plan needs prior authorization. No charge, no commitment.
Check my coverage — free → (sponsored affiliate link, opens in a new tab)Sponsored link · free report · no commitment
What we actually verified — Last verified:
We checked the FDA approval and Zepbound prescribing information, CMS guidance on Medicare GLP-1 coverage and the GLP-1 Bridge, published prior-authorization criteria from UnitedHealthcare, Highmark, Aetna, and Cigna, CVS Caremark's 2026 formulary update, Eli Lilly's official coverage and savings resources, and current telehealth pricing from Ro and Sesame. Your exact plan can still differ — that's why the scripts and checklists below tell you precisely what to confirm.
Does insurance cover GLP-1 for sleep apnea?
Sometimes — and "sometimes" comes down to two things: the drug and the diagnosis. Insurance may cover a GLP-1 for sleep apnea when the drug is Zepbound and the prescription is written for obstructive sleep apnea, not weight loss. The FDA approved Zepbound for moderate-to-severe sleep apnea in adults with obesity in December 2024, but each plan still controls its own formulary, its prior-authorization rules, and its exclusions.
"GLP-1" is a class of drugs — a family. Asking "does insurance cover a GLP-1 for sleep apnea" is a bit like asking "does insurance cover a car repair." Depends on the car. Depends on the repair. For sleep apnea, the clean path is one specific drug, for one specific reason: Zepbound is the only one with the FDA's stamp for treating sleep apnea. That single fact is your leverage — and most people waste it by asking the wrong question first.
Ask this question — not the one everyone asks
When you call your insurer, don't open with "Do you cover weight-loss drugs?" That question often gets you a fast "no" and a quick goodbye. Ask this instead:
Same drug. Completely different question. One sounds like a diet request. The other sounds like treatment for a serious medical condition — which is exactly what it is. If a sleep study put a number on your apnea, you're not hunting for a loophole. You're asking for treatment for a condition the FDA recognizes.
Does insurance cover Zepbound for sleep apnea specifically?
Some plans do, and Zepbound is the only GLP-1 they'll consider for this reason, because it's the only one FDA-approved for obstructive sleep apnea. Coverage almost always requires prior authorization, plus proof of moderate-to-severe sleep apnea and obesity. Plans that exclude weight-loss drugs sometimes still have a path for Zepbound when it's prescribed for sleep apnea — but you have to ask for that path by name.
Which GLP-1 actually qualifies for sleep apnea coverage?
For sleep apnea, the qualifying medication is Zepbound (tirzepatide) — full stop. It's the only GLP-1/GIP medication FDA-approved to treat obstructive sleep apnea. Ozempic, Wegovy, and Mounjaro are not approved for sleep apnea, and compounded versions aren't FDA-approved finished drugs.
| Medication | Active ingredient | FDA-approved for sleep apnea? | Will insurance cover it for sleep apnea? |
|---|---|---|---|
| Zepbound | tirzepatide | Yes — moderate-to-severe OSA + obesity (Dec 2024) | Possible, with prior authorization. This is the path. |
| Mounjaro | tirzepatide | No — diabetes only | No (it's covered for diabetes, a different door) |
| Wegovy | semaglutide | No — obesity / heart-risk | No |
| Ozempic | semaglutide | No — diabetes | No |
| Compounded tirzepatide / semaglutide | compounded preparation | No — not FDA-approved finished drugs | Don't count on it — insurance generally won't pay for compounded drugs |
A few quick notes so you're not surprised on the phone:
Ozempic and Wegovy use semaglutide, a different molecule. Losing weight generally helps sleep apnea, but "generally helps" isn't an FDA approval — and insurers cover the approved use, not the helpful side effect.
Mounjaro is the same molecule as Zepbound (tirzepatide), just approved for type 2 diabetes. If you have diabetes, that's a separate — often easier — coverage path. It's not the sleep apnea path.
For sleep apnea, Zepbound's maintenance dose is 10 mg or 15 mg once a week. That's higher than the starting dose — so a cheap "starter" price isn't what you'll pay long-term.
Will your type of insurance cover it?
Whether you're covered depends mostly on your plan type — and on one key fact: plans that exclude weight-loss drugs sometimes still cover Zepbound for sleep apnea, because sleep apnea is a separate medical diagnosis. Across plans that do cover Zepbound, prior authorization is almost always required — roughly 88% of covering plans ask for it first.
| Your coverage | Can it cover Zepbound for sleep apnea? | The deciding factor | If covered, you might pay… | Move to make first |
|---|---|---|---|---|
| Commercial / employer plan that covers obesity meds | Most likely yes, with prior auth | Formulary + documentation | as little as $25/mo with the Zepbound Savings Card (commercial coverage, terms apply) | Run a coverage check, then submit the sleep apnea prior auth |
| Commercial plan that EXCLUDES weight-loss meds | Sometimes — if the plan has a sleep apnea coverage path or exception | OSA is a separate indication | Your plan's copay after prior auth | Ask your doctor to submit for sleep apnea, not weight loss |
| Medicare Part D | Yes — for sleep apnea, not weight loss | OSA diagnosis + obesity + prior auth | capped by the 2026 Part D out-of-pocket max of $2,100 | Use regular Part D — not the $50 Bridge (see below) |
| Medicaid | Varies by state | State drug list + prior auth | State-dependent | Ask your state's Medicaid program about the OSA path specifically |
| Uninsured / self-pay | No insurer involved | — | LillyDirect self-pay ~$299-$449/mo by dose vs. ~$1,086 retail | Compare LillyDirect vs. a brand telehealth route |
Coverage shifts fast — and not always in your favor. In 2025, CVS Caremark dropped Zepbound from its main commercial formulary. Then in May 2026, CVS reversed course: it announced Zepbound will return as a preferred option on its commercial formularies on October 1, 2026 — though each employer still decides whether to follow that list. Always confirm live status before you rely on it.
And here's the encouraging part for sleep apnea specifically: Zepbound carries the strongest medical-necessity argument of any GLP-1, because it's the only one approved for obstructive sleep apnea. That's why the sleep apnea path is worth pursuing even when a plain weight-loss request got denied.
Quick self-check: is the sleep apnea coverage path likely for you?
Run down this list before you spend a dollar. The more boxes you can check, the stronger your case:
- ☐You have a sleep study (in-lab or at-home) showing your apnea is moderate-to-severe — usually an AHI of 15 or higher. (No study yet? That's step one — insurers need it on paper.)
- ☐Your BMI is 30 or higher, with a recent height and weight in your chart.
- ☐Your prescription is written for sleep apnea (diagnosis code G47.33) — not "weight loss."
- ☐You can get your doctor (ideally with a sleep specialist) to submit a prior authorization.
- ☐You know your plan type (commercial, Medicare Part D, or Medicaid) so you ask the right questions.
Check most of these and you have a real, plausible path. Miss the sleep study or the BMI, and that's where to start — not with a provider sign-up.
What proof does insurance want before it says yes?
Most plans want three things up front: a sleep study showing moderate-to-severe sleep apnea (usually an AHI of 15 or higher), a BMI of 30 or higher, and your plan's specific extras. Get all three attached to the prior authorization the first time, and approval is far more likely. The number-one reason for denial isn't being ineligible — it's missing paperwork.
AHI stands for apnea-hypopnea index — the number of times your breathing stops or goes shallow per hour of sleep. An AHI of 15 or higher is the line between mild and moderate sleep apnea — and that's the number most insurers want to see.
Your coverage-ready checklist
Gather these before your doctor submits anything:
- ✅Your insurance card
- ✅A coverage-check result or formulary lookup for Zepbound
- ✅Your sleep apnea diagnosis (the code is usually G47.33, for obstructive sleep apnea)
- ✅Your sleep study — in-lab (polysomnography) or an at-home sleep test
- ✅Your AHI number (15 or higher is the threshold most plans use)
- ✅Your BMI, plus a recent height and weight (30 or higher is standard for this indication)
- ✅Your CPAP/PAP history, if you have one (some plans ask)
- ✅A note from your prescriber or sleep specialist
- ✅A letter of medical necessity, ready in case you get denied
What the big insurers actually require
Published prior-authorization criteria differ by company — and the differences can sink an approval if you don't know them. This is a snapshot; confirm your own plan's live policy, because these change.
| Insurer | What their published sleep apnea criteria center on | What it means for you |
|---|---|---|
| Aetna | An AHI of 15 or higher on a sleep study plus a BMI of 30 or higher, with documentation | Your sleep study and BMI are the first two things to nail down |
| UnitedHealthcare (OSA-only policy) | Adult age, BMI of 30 or higher, sleep-study evidence with an AHI/REI/RDI threshold, your CPAP/PAP history, and a sleep specialist involved; initial approval usually runs 6 months | UHC is documentation-heavy — have a sleep specialist on board and your CPAP records ready |
| Cigna | Adult age, BMI of 30 or higher, and a sleep study showing moderate-to-severe obstructive sleep apnea (AHI of 15 or higher) | Because Zepbound is approved for obstructive sleep apnea, it won't be covered for central sleep apnea |
| Highmark | Whether you have OSA, whether a sleep specialist is involved, and your baseline AHI/RDI from sleep testing | A missing baseline AHI/RDI is a common reason these get bounced |
Now that you know what's required, find out if your plan actually recognizes the sleep apnea path.
Ro's free checker reports whether your plan covers Zepbound and whether prior authorization applies — before you pay for a visit.
See if my plan covers it → (sponsored affiliate link, opens in a new tab)Related guides:
- Obesity ICD-10 codes for GLP-1 prior authorization — get the diagnosis coding right
Does Medicare cover GLP-1 for sleep apnea?
Yes — Medicare can cover Zepbound for sleep apnea through standard Part D, because sleep apnea is a covered medical use and not "weight loss alone." This is not the new $50 Medicare GLP-1 Bridge, which is for weight-loss coverage only. People getting Zepbound for sleep apnea use their regular Part D plan, with prior authorization.
This is the single biggest mix-up we see, and getting it wrong sends people down a dead end. There are two different Medicare doors — and your door is Door 1.
| Door 1: Regular Part D (your door) | Door 2: The Medicare GLP-1 Bridge | |
|---|---|---|
| For what? | Sleep apnea (with obesity) | Weight loss only |
| Who walks through it | Sleep apnea patients — that's you | People getting it purely for weight management |
| How it works | Standard Part D covers Zepbound for the sleep apnea diagnosis, with prior auth | A temporary program: flat $50/month, July 1, 2026 - December 31, 2027 |
| What you pay | Plan copay, capped by the 2026 Part D out-of-pocket max of $2,100 | $50/month (doesn't count toward your Part D cap) |
| Does it apply if you have sleep apnea? | Yes | No — sleep apnea patients are excluded from the Bridge |
Why does Door 2 not apply to you? Because the Bridge exists for the weight-loss use that regular Part D won't cover. If your drug is already coverable under regular Part D — and Zepbound for sleep apnea is — you use Part D, not the Bridge.
So if you're on Medicare, don't call and ask, "Can I get the $50 Bridge?" Ask: "Is Zepbound on my Part D formulary for obstructive sleep apnea, and what's the prior authorization?"
Going deeper on Medicare? See: Does Medicare Cover Zepbound? The 3 Paths and Medicare GLP-1 Bridge: $50 copay explained
What about Medicaid?
Medicaid coverage for Zepbound is state-specific, and the sleep apnea path is often separate from weight-loss coverage. Some states cover GLP-1s for obesity; many don't. But because sleep apnea is its own medical diagnosis, your state may handle it differently than a weight-loss request.
Ask your state Medicaid program three things: whether it covers Zepbound for obstructive sleep apnea (separate from weight loss), whether prior authorization is required, and whether the drug sits on the state's preferred drug list. Your prescriber's office often knows the state-specific answer faster than the helpline does.
What if your insurance denies it — or calls it "weight loss"?
A denial usually isn't a verdict — it's a paperwork problem, and sleep apnea gives you the strongest appeal of any GLP-1. First, get the denial reason in writing. Then figure out which of four buckets you're in: wrong indication, missing documents, formulary issue, or a true plan exclusion.
We hear the same frustrations over and over: plans that "only cover it if it's for sleep apnea," requests rejected two or three times, and the maddening one — a plan that acknowledges the right diagnosis and still miscategorizes it as weight loss. If that's you, you're not imagining it, and you're not stuck. Here's how to read your denial and push back.
Denial decoder: what the words mean and what to do
| What the denial says | What it probably means | Your next move |
|---|---|---|
| "Weight-loss drugs are excluded" | They treated it as a diet request | Appeal with the sleep apnea diagnosis + sleep study + BMI + the FDA approval |
| "Non-formulary" | The drug isn't on your plan's list | Ask for a formulary exception |
| "Prior authorization denied" | Criteria not met, or documents missing | Request the written criteria and the denial letter, then resubmit complete |
| "Not medically necessary" | They're disputing the need | Add a sleep specialist letter and your objective AHI from the sleep study |
| "Plan exclusion" | Your employer/plan may not cover it at all | Ask HR whether the exclusion applies to sleep apnea too, not just weight loss |
The appeal angle that fits the diagnosis
Lead with the diagnosis, not the diet. Your provider can submit prior authorization with a letter of medical necessity, and if it's denied, they can file an appeal. Attach the AHI, the BMI, the sleep study, and the OSA code (G47.33). The argument is straightforward: this is the only FDA-approved medicine for this condition — but remember, your plan still controls coverage.
When an appeal won't win — and what to do instead
No telehealth service, no concierge, and no appeal can force an excluded benefit to become covered. If your plan document says Zepbound is excluded for every indication, you can fight it forever and still lose.
- Escalate to your HR/benefits team (employer plans sometimes have more room than the PBM admits)
- Compare plans during open enrollment
- Move to a self-pay route for real, FDA-approved Zepbound (see costs below)
- Or take our quiz if you're not sure which lane fits
Should you use Ro, Sesame, or your own sleep doctor?
It depends on what you actually need: documentation, coverage help, lower care costs, or a cash-pay backup. If you already have a sleep doctor willing to run the prior authorization, start there — it's your cheapest path.
You already have a sleep specialist with your records?
Start with them. Their office has your sleep study, your AHI, your BMI, and your CPAP history — exactly what insurers want. They can submit a clean sleep apnea prior auth without you paying anything extra.
You have insurance but no idea what's covered?
Run a free coverage check first. Ro's free GLP-1 Insurance Coverage Checker reports whether your plan covers the medication and whether prior authorization is required. Ro carries FDA-approved Zepbound and Foundayo, and its paid Body program can include insurance-concierge support if a Ro-affiliated provider prescribes.
You want lower ongoing care fees or provider choice?
Look at Sesame. Its weight-loss program, Success by Sesame, starts at $99/month (as low as $59/month with annual or Costco-member pricing), its providers help with prior-authorization paperwork, and its self-pay Zepbound runs the same LillyDirect cash prices ($299-$449/month by dose). It's a strong option if you want to compare live care with lower monthly fees.
Your plan flatly won't cover it?
Go straight to official cash-pay. LillyDirect and the Zepbound Savings Card are Lilly's own routes.
The honest catch on Ro
Ro is not the cheapest way to get this prescription. If you already have a sleep doctor who'll run your prior authorization, that's your cheaper path — go straight to them and skip the membership entirely. But if you don't have that — or your doctor's office won't wrestle with the insurance fight — then Ro's free coverage check and concierge support are built for exactly that headache. You're not paying for the pill. You're paying to make the coverage maze somebody else's job.
Ro's membership runs $39 for the first month, then $149/month if you pay monthly, or as low as $74/month with the annual plan paid upfront — and the medication cost is separate.
If you'd rather have someone check your coverage and help with the paperwork, start here.
Ro runs a free coverage check first — so you know where you stand before you commit to anything.
Check my coverage with Ro → (sponsored affiliate link, opens in a new tab)Prefer to compare a live-care option with lower monthly fees?
See Sesame's weight-loss program →Sponsored link
What will it cost — covered or not?
If insurance covers it, you could pay as little as $25/month with a commercial plan and the savings card; on Medicare, the 2026 Part D cap of $2,100 limits your yearly out-of-pocket. With no coverage, real Zepbound runs about $299-$449/month through LillyDirect by dose, versus roughly $1,086 at retail. Prices and programs change often, so reverify before you decide.
| Your situation | What you might pay | Notes |
|---|---|---|
| Commercial plan + Zepbound Savings Card | as little as $25/mo | Commercial coverage required; terms apply |
| Medicare Part D (sleep apnea) | capped by the 2026 Part D max of $2,100/yr | After you hit the cap, covered drugs cost $0 |
| Self-pay — LillyDirect vials | $299 (2.5mg) · $399 (5mg) · $449 (7.5-15mg) | Higher doses hold the $449 price when you refill on time |
| No discount, retail pens | ≈ $1,086 / month | The list price almost nobody actually pays with a savings program |
GLP-1 prices have moved several times in the last year. Re-check Ro, Sesame, LillyDirect, and your plan's formulary before you commit.
For a full breakdown of FDA-approved cash-pay options, see our GLP-1 cost without insurance guide.
The exact words to use with your doctor and insurer
Use the sleep apnea language every time — not vague "GLP-1" or "weight loss" wording. The right words can be the difference between an approval and a denial. Save these — copy the one that fits before you pick up the phone.
To your doctor:
"I have obstructive sleep apnea and obesity. I want to know if Zepbound's FDA-approved sleep apnea indication applies to me. Can we review my sleep study, AHI, BMI, and CPAP history — and would you support a prior authorization for sleep apnea, not weight loss?"
To your insurer:
"Does my plan cover Zepbound for FDA-approved moderate-to-severe obstructive sleep apnea in adults with obesity? If prior authorization is required, what criteria and documents do you need?"
To open your appeal (if denied):
"This request is for Zepbound's FDA-approved indication for moderate-to-severe obstructive sleep apnea in adults with obesity — not for cosmetic weight loss."
To your HR/benefits team (employer plans):
"Does our plan exclude Zepbound only for weight management, or does it exclude Zepbound even when it's prescribed for FDA-approved obstructive sleep apnea?"
When you're on the phone, write down:
- The rep's name, the date and time
- Whether Zepbound is on your formulary
- Whether the sleep apnea indication is covered
- The exact prior-auth criteria
- The appeal deadline
- Where to send the prior auth
- Your reference number
Phone summaries vanish. Notes win appeals.
What are the real risks and limits?
Zepbound is a serious prescription medicine, not a shortcut — and it isn't right for everyone. It carries warnings including a risk of thyroid C-cell tumors, pancreatitis, gallbladder problems, kidney injury, and low blood sugar, plus common side effects like nausea, diarrhea, vomiting, and constipation. Sleep apnea is a real health condition, and the decision to treat it with medication belongs with a licensed clinician.
It's not for everyone. People with a personal or family history of medullary thyroid cancer or MEN 2, or a serious allergy to tirzepatide, shouldn't take it. Your prescriber will screen for this. Read the full prescribing information for the complete warnings.
Weight loss may not "cure" your sleep apnea. Some sleep apnea is driven by airway anatomy, jaw structure, or central (brain-signal) causes that weight loss won't fix. Don't expect a guarantee.
CPAP still matters. PAP therapy (the CPAP-style machine) is still the standard treatment for moderate-to-severe sleep apnea. In the approval studies, one group used PAP and one couldn't or wouldn't — Zepbound helped in both, but it's not an automatic replacement. Don't ditch your machine without your doctor's say-so.
Your next step, based on your situation
The fastest path is to name your lane and take the one action that fits it.
- 1.Commercial insurance + a sleep study? Run a free coverage check and ask specifically about the sleep apnea indication.
- 2.Medicare? Confirm Zepbound for sleep apnea under regular Part D, not the Bridge. Does Medicare Cover Zepbound?
- 3.Already denied? Get the denial letter, find your bucket, and appeal with the sleep apnea diagnosis.
- 4.No sleep study yet? Talk to a sleep specialist first — insurers need objective proof.
- 5.Paying cash? Compare LillyDirect and a brand telehealth route before you commit. See GLP-1 cash-pay costs →
Still not sure which GLP-1 program is right for you?
Take our free 60-second matching quiz and get a personalized action plan — coverage check, prior authorization prep, Medicare route, or cash-pay comparison.
Start the quiz →Or check commercial coverage free with Ro → (sponsored affiliate link, opens in a new tab)Frequently asked questions
- Does insurance cover GLP-1 for sleep apnea?
- Sometimes. The clean covered path is Zepbound for moderate-to-severe obstructive sleep apnea in adults with obesity. Your plan still has to cover it and approve a prior authorization, which usually requires a sleep study (AHI of 15 or higher) and a BMI of 30 or higher.
- Is Zepbound the only GLP-1 approved for sleep apnea?
- Yes. Zepbound (tirzepatide) is the only GLP-1/GIP medication FDA-approved to treat obstructive sleep apnea, approved in December 2024 for moderate-to-severe OSA in adults with obesity. Ozempic, Wegovy, and Mounjaro are not approved for sleep apnea.
- Does Medicare cover Zepbound for sleep apnea?
- Yes - through standard Medicare Part D, because sleep apnea is a covered medical use and not weight loss alone. Coverage depends on your plan's formulary and prior-authorization rules. This is separate from the $50 Medicare GLP-1 Bridge.
- Does the Medicare GLP-1 Bridge cover Zepbound for sleep apnea?
- No. The Bridge is for weight-management use only and runs July 1, 2026 through December 31, 2027. If your prescription is for sleep apnea - a use already coverable under Part D - you use regular Part D instead, and you're not eligible for the Bridge.
- What BMI and sleep apnea diagnosis do I need for coverage?
- Most plans require moderate-to-severe obstructive sleep apnea documented by a sleep study with an AHI of 15 or higher, plus a BMI of 30 or higher. The diagnosis code is usually G47.33.
- What if my plan denies Zepbound as weight loss?
- Get the denial reason in writing, then appeal using the sleep apnea diagnosis, your sleep study, your BMI, and a letter of medical necessity. An appeal can work when the denial was caused by the wrong indication, missing documentation, or a formulary-exception issue, but it won't override a true plan exclusion.
- Can Ozempic or Wegovy be covered for sleep apnea?
- Don't count on it. Ozempic and Wegovy use semaglutide and are not FDA-approved for sleep apnea, so insurers won't cover them for that condition. The approved path is Zepbound.
- Can compounded tirzepatide be covered for sleep apnea?
- No. Compounded tirzepatide is not an FDA-approved finished drug for sleep apnea and is not the same as Zepbound for insurance purposes. You shouldn't count on insurance paying for compounded medications.
- How much does Zepbound cost for sleep apnea?
- With commercial insurance and the savings card, as little as $25/month. On Medicare Part D, your yearly cost is capped by the 2026 out-of-pocket maximum of $2,100. Without coverage, LillyDirect self-pay vials run $299-$449/month by dose, versus roughly $1,086 at retail.
Related guides from The RX Index
- Does insurance cover Zepbound for sleep apnea? (full guide)
- Does insurance cover Zepbound for weight loss?
- Does Medicare cover Zepbound? The 3 paths
- Medicare GLP-1 Bridge: $50 copay explained
- Best GLP-1 providers that accept insurance
- Obesity ICD-10 codes for GLP-1 prior authorization
- GLP-1 cost without insurance: FDA-approved cash-pay options
- Free GLP-1 insurance coverage checkers: 7 tools compared
- Does insurance cover GLP-1 for high blood pressure?
- Does insurance cover GLP-1 for prediabetes?
- Does insurance cover GLP-1 for high cholesterol?
- Free 60-second GLP-1 matching quiz
Sources
- FDA / Eli Lilly — Zepbound approved for moderate-to-severe OSA in adults with obesity (Dec 20, 2024) — investor.lilly.com
- FDA — Compounding and the FDA: Questions and Answers — fda.gov
- WebMD — Zepbound for obstructive sleep apnea — webmd.com
- UnitedHealthcare — Zepbound OSA-only prior-authorization policy — uhcprovider.com
- Highmark — Zepbound prior-authorization form — providers.highmark.com
- CMS — Medicare GLP-1 Bridge (July 1, 2026-Dec 31, 2027) — cms.gov
- CMS — Draft CY 2026 Part D Redesign fact sheet ($2,100 out-of-pocket cap) — cms.gov
- KFF — BALANCE Model and Medicare GLP-1 Bridge extension — kff.org
- CVS Health — 2026 commercial formulary update (Zepbound returning Oct 1, 2026) — cvshealth.com
- Eli Lilly — Zepbound access, coverage, and appeals — zepbound.lilly.com
- Eli Lilly — Zepbound Savings Card (from $25, commercial coverage, terms apply) — zepbound.lilly.com/savings
- LillyDirect — Zepbound self-pay pricing ($299/$399/$449 by dose) — lilly.com/lillydirect
- Ro — GLP-1 Insurance Coverage Checker; Medicare + Zepbound for OSA; pricing — ro.co
- Sesame — Success by Sesame weight-loss program pricing — sesamecare.com
- GBC Health — Zepbound coverage overview (prior-authorization prevalence) — gbchealth.org
All facts current as of . Coverage rules, pricing, and program terms change frequently — confirm current details with your plan, provider, or CMS before you act.